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ABSTRACT
Themammalianabasic-endonuclease1/redox-factor1
(APE1/Ref1)isanessentialproteinwhosesubcellular
distributiondependsonthecellularphysiologicalsta-
tus.However,itsnuclearlocalizationsignalshavenot
been studied in detail. We examined nuclear translo-
cation of APE1, by monitoring enhanced green fluor-
escent protein (EGFP) fusedto APE1. APE1’s nuclear
localization was significantly decreased by deleting
20aminoacidresidues fromitsN-terminus.Fusionof
APE1’s N-terminal 20 residuesdirected nuclear local-
izationofEGFP.AnAPE1mutantlackingthesevenN-
terminal residues (ND7 APE1) showed nearly normal
nuclear localization, which was drastically reduced
when the deletion was combined with the E12A/
D13A doublemutation. Ontheotherhand,nearlynor-
mal nuclear localization of the full-length E12A/D13A
mutantsuggeststhatthefirst7residuesandresidues
8–13 can independently promote nuclear import.
Both far-western analyses and immuno-pull-down
assays indicate interaction of APE1 with karyopherin
alpha 1 and 2, which requires the 20 N-terminal resi-
duesandimplicatesnuclearimportinsinAPE1’snuc-
lear translocation. Nuclear accumulation of the ND7
APE1(E12A/D13A) mutant after treatment with the
nuclear export inhibitor leptomycin B suggests the
presence of a previously unidentified nuclear export
signal, and the subcellular distribution of APE1 may
be regulated by both nuclear import and export.
INTRODUCTION
The integrity of the genome is continuously challenged by
endogenous reactive oxygen species (ROS) and by exogenous
toxic reagents, including environmental carcinogens and
ionizingradiation (1,2). DNAdamageofvarious types,includ-
ing abnormal bases, apurinic/apyrimidinic (AP) sites, DNA
single-strand breaks (SSBs) and DNA double-strand breaks
(DSBs), is induced by these genotoxic reagents (2–4). Except
for DSBs, these lesions are repaired primarily via the DNA
base excision repair (BER) process (5). For damaged bases,
DNA glycosylases hydrolyze the N-glycosylic bonds (6,7);
subsequent repair requires generation of the 30-OH primer.
In mammalian cells, this reaction is efﬁciently carried out
by the sole AP-endonuclease (APE1) (8,9). Moreover, recent
reports suggest that APE1 is also critical for nuclear incision
repair which does not involve AP sites as intermediates (10).
Besides its crucial role in BER, APE1 plays an important
role in gene regulation; it was independently identiﬁed as the
redox factor 1, Ref1, which activates AP-1 (cJun/cFos) and
other transcription factors (11–16). Furthermore, APE1 was
also discovered as a co-repressor which downregulates the
parathyroid hormone gene upon calcium inﬂux (17–19).
APE1 is acetylated at Lys-6 and Lys-7 by the histone acetyl-
transferase p300, and that this posttranslational modiﬁcation
stimulates the co-repressor activity (20). APE1 is essential for
the embryonic development of mice (21–23), as homozygous
APE1 knockout mice die 3.5–5.5 days after implantation (23).
Although it is still unclear which function of APE1 is required
in embryonic development, it is obvious that nuclear localiza-
tion is a prerequisite for functions of APE1 and other DNA
repair proteins (24). Recent reports indicate that the level of
APE1 determines the sensitivity of cancerous cells, affecting
the drug resistance and recurrence rate of tumors (25,26). Thus
understanding and controlling the nuclear transport of APE1 is
signiﬁcant to cancer biology.
There are several previous reports on the subcellular local-
ization of APE1. Although a large fraction of APE1 molecules
in human cell lines was present in the cytoplasm, APE1 was
translocated into nuclei after exposure of these cells to oxid-
ative stress (27). Therefore, the nuclear versus cytoplasmic
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doi:10.1093/nar/gki641distribution of APE1 may be conditional, which is consistent
with the variable nuclear/cytoplasmic distribution of this
protein observed in various human tissues (28,29). Fan et al.
(30) reported that the majority of abasic-endonuclease1/
redox-factor1 (APE1/Ref1) molecules in T cells were in the
cytoplasm, particularly in the perinuclear region, and were
associated with the granzyme A complex. APE1 was translo-
cated to the nucleus after proteolysis at residue 31, and then
degraded rapidly. However, this regulated nuclear transport
may be speciﬁc for the cytolytic T cells (30). Using transiently
expressed APE1-FLAG fusion polypeptide, Takao et al. (31)
showed that APE1 was localized exclusively in the nuclei in
HeLa cells. Together, these studies indicate that APE1’s nuc-
lear transport and accumulation is rather complex.
Karyopherin a (Kap a, also known as importin a) recog-
nizes the nuclear localization signals (NLS) of target proteins,
and plays a crucial role for importing nuclear proteins as an
adaptor protein (32). Kap a also interacts with karyopherin b1
(Kap b1—also known as importin b); together, these proteins
form the transportation machinery by which a protein contain-
ing a classical NLS is imported by the Kap a–Kap b1 het-
erodimer (32). A classical type of NLS has been characterized
by four residue pattern consisting of either four basic amino
acids (Lys or Arg), or three basic amino acids and a His or Pro.
Another classical type, containing seven amino acid residues,
begins with a Pro, followed by a cluster of basic residues (33).
The Kap a proteins interact with these classical NLS to trans-
port them into nuclei (34).
Although a putative NLS of the classical pat7 type is found
at APE1’s N-terminus (with the segment ‘PKRGKK’ starting
at residue number 2) (31), its function as an NLS was not
directly demonstrated. Moreover, while the NLS directs pro-
teins into the nucleus, nuclear accumulation can also be regu-
lated by inhibiting nuclear export of proteins containing
nuclear exporting signals (NES). To elucidate the mechanism
of APE1 nuclear trafﬁcking and its regulation, we carried out
systematic analysis of the N-terminal sequence of APE1 (iden-
tifying a complex, bipartite NLS in APE1) and the interaction
of APE1 with the Kap a proteins. Furthermore, our results
suggest the presence of an NES that responds to leptomycin B,
an inhibitor of the nuclear export protein CRM1.
MATERIALS AND METHODS
Cell culture
The mouse BALB/c 3T3 ﬁbroblast line was a gift from
Dr M. Tatsuka (Hiroshima University, Japan), and a human
colon carcinoma cell line HCT116 was obtained from
Dr B. Vogelstein (35). These cells were grown in DMEM with
10% fetal bovine serum (FBS) and streptomycin/penicillin.
Transfection studies
Cells grown on cover slips in 35 mm dishes were transfected
with 0.5 mg plasmid DNA, using Lipofectamine 2000 and
OptiMEM I (Invitrogen), then incubated at 37 Ci n5 %
CO2. The cells were washed 6 h later and incubated with
2 ml of DMEM containing 10% FBS. After further incubation
for 24 h, the cells were washed with PBS twice, and ﬁxed with
paraformaldehyde solution (16% in normal saline) for 30 min
at 4 C, and then rinsed with PBS three times. The cells were
permeabilized with Triton X solution for 30 min and incubated
with propidium iodide for another 5 min before the cells were
rinsed with PBS, and visualized in a confocal microscope
(LSM510Meta, Carl Zeiss) at UTMB’s Optical Image Core.
For live cell analysis, cells spread on glass-coated 35 mm
dishes (Mattek) were transfected with DNA as described
above, and then examined without ﬁxation. Intensity of
enhanced green ﬂuorescent protein (EGFP) ﬂuorescence in
cells was quantiﬁed using the digital image generated by
the microscope, and with analytical software (MetaMorph).
To compare average (area-standardized) intensity of EGFP in
nuclei and cytoplasm, the average intensities of the nuclear
and total cell areas were measured and the ratios of nuclear to
total EGFP intensities were calculated. Fixed cells were used
for the measurement, for which the nuclear area was determ-
ined by propidium iodide staining. More than 30 individual
cells were analyzed for all transfection experiments.
Plasmid DNA
The IkBa-EGFP fusion construct was a gift from Dr T.J. Hope
(36). The human APE1 cDNA was originally a gift from
Dr S. Seki, and was cloned into various vectors as previously
described (8,37–39). The EGFP gene (pEGFP-N1, Clontech)
was inserted into pcDNA 3.1Zeo(+) (Invitrogen) with EcoRI
and NotI. The wild-type (WT) APE1 cDNA was then inserted
into this vector using newly created BamHI and EcoRI sites at
APE1’s 50 and 30 ends, respectively. The primers for PCR were
50-TTG GAT CCA CCA TGC CGA AGC GTG GGA AAA
AGG GA-30 and 50-CCG AAT TCG CAG TGC TAG GTA
TAG GGT GAT AGG-30. There are 51 nt between the last
codon of APE1and the initiationcodonof EGFP,resultingina
17 amino acid insertion. Several N-terminal deletions and
missense mutations of the APE1 coding sequence were then
created in the EGFP fusion vector by PCR cloning, using the
WTAPE1-EGFP vector as a template. Table 1 summarizes the
N-terminal sequences of those APE1-EGFP fusion proteins.
The identities of generated PCR plasmids were conﬁrmed by
DNA sequencing at UTMB’s Protein Chemistry Core facility.
A FLAG epitope tag was introduced at the APE1 C-terminus
by inserting a linker containing EcoRI and XhoI site. The
linker replaced the EGFP sequence from the WT APE1-
EGFP vector. The linker sequences were 50-AAT TCT CTG
TCG ACT ACA AAG ACG ATG ACG ACA AGT AAC-
30 and 50-TCG AGT TAC TTG TCG TCA TCG TCT TTG
TAG TCG ACA GAG-30.
Oligonucleotides
GFP oligonucleotides were purchased from Invitrogen. The
Oligos included: ND41 (50-TTT GGA TCC ACC ATG GCC
CTG TAT GAG GAC CCC CCA GAT CAC AAA ACC
TCA CCC AGT-30), ND20 (50-TTT GGA TCC ACC ATG
GAG GCC AAG AAG AGT AAG ACG GCC GCA AAG
AAA AAT GAC AAA GAG GCA GCA GGA GAG-30), ND7
(50-TTT GGA TCC ACC ATG GGA GCG GTG GCG GAA
GAC GGG GAT GAG CTC AGG ACA-30), K6L/K7L (50-
TTT GGA TCC ACC ATG CCG AAG CGT GGG CTC CTC
GGA GCG GTG GCG GAA GAC GGG GAT-30), K6R/K7R
(50-TTT GGA TCC ACC ATG CCG AAG CGT GGG AGG
AGG GGA GCG GTG GCG GAA GAC GGG GAT GAT
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ATG CCG CTC CGT GGG CTC CTC GGA GCG GTG
GCG GAA GAC GGG GAT-30), N20 (50-TTT GGA TCC
ACC ATG CCG AAG CGT GGG AAA AAG GGA GCG
GTG GCG GAA GAC GGG GAT GAG CTCAGG ACA
GAG-30), ND7(V10A) (50-TTT GGA TCC ACC ATG GGA
GCG GCG GCG GAA GAC GGG GAT GAG CTCAGG
ACA GAG-30), ND7(E12A/D13A) (50-TTT GGA TCC
ACC ATG GGA GCG GTG GCG GCG GCG GGG GAT
GAG CTCAGG ACA GAG-30), WT-APE(E12A/D13A)
(50-TTT GGA TCC ACC ATG CCG AAG CGT GGG
AAA AAG GGA GCG GTG GCG GAA GAC GGG GAT
GAG CTCAGG ACA GAG-30).
Analysis of leptomycin B-treated cells
The cells were transiently transfected with plasmids encoding
EGFP fusion proteins, and 24 h later treated with 5 nM lep-
tomycin B (LMB, Sigma), a nuclear export inhibitor, for 2 h.
The location of IkB, a control for LMB-inhibited nuclear
export (36), was determined along with that of WT APE1
and its mutants. All cells were analyzed by confocal ﬂuores-
cence microscopy (LSM510Meta, Carl Zeiss).
Protein purification
APE1, WT and the deletion mutants (ND20 and ND33) were
puriﬁed as previously described (37). Human Kap a2 protein,
tagged N-terminally with a histidine hexamer (40), was puri-
ﬁed using Ni-NTA column chromatography as before (37)
after expressed in Escherichia coli BL21 (Stratagene) harbor-
ing the pET-Kap a2 plasmid vector (a gift from Dr G. Blobel).
Detection of APE1 protein by His-Kap a2 pull-down
assay
An Ni-NTA magnetic bead (Qiagen) suspension (50 ml) was
added to 500 ml of the His-tagged Kap a2 protein (15 mg) in a
microcentrifuge tube and the suspension was incubated on an
end-over-end shaker for 30 min at room temperature. After
separatingthesupernatant,500mlofinteractionbuffer(50mM
NaH2PO4, 300 mM NaCl, 20 mM imidazole and 0.005%
Tween-20, pH 8.0) was added to each tube. After mixing,
this was placed on the magnetic separator for 1 min, and
then the buffer was removed. APE1 (3 mg) in 500 ml interac-
tion buffer was added to each tube and incubated on an
end-over-end shaker for 1 h at room temperature, and again
the supernatant was removed on a magnetic separator, and
washed twice with 500 ml of the interaction buffer. The
APE1/Kap a2 mixture was then eluted with 50 mlo f1 ·
SDS–PAGE loading buffer, and the presence of APE1 protein
was examined by SDS–PAGE followed by western analysis
with anti-APE1 antibody.
Far-western analysis
WTandtruncated APE1proteins(10–40 pmol)wereseparated
by 12% SDS–PAGE and transferred to a nitrocellulose mem-
brane. The membrane was washed with cold 1· PBS and
treated with 6 M guanidine–HCl in PBS at 4 C. The proteins
were then renatured with successive dilutions of guanidine–
HCl in PBS, diluted by 1 mM DTT in PBS at 4 C (41). After
blocking with 5% nonfat dry milk (NFDM) in PBS/0.5%
Tween-20 for 1 h at 4 C, the membrane was incubated
with 10 pmol of Kap a2 in 0.5% NFDM/PBS/0.5% Tween-
20 containing 1 mM DTT and 100 mM trimethylamine-N-
oxide dihydrate (TMAO) for 3 h at 4 C (41). Subsequent
immunoblot analysis was performed using anti-Kap a2
antibody (Santa Cruz) followed by anti-Goat IgG antibody
and detected using ECL (Amersham Biosciences).
APE1-FLAG immunoprecipitation
HCT116 cells were transfected with 5 mg control vector (pcD-
NAZeo3.1) or FLAG-tagged WT APE1 using liptofectamine
2000 (Invitrogen). The cells were then lysed by adding 1 ml of
lysis buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1 mM
EDTA, 1% Triton X-100 and 1 mM PMSF, Protease Inhibit-
ors, Roche) to each culture dish and incubating on ice for
30 min. Plates were scraped and cell lysate was placed in a
centrifuge tube. Protein concentration of cell lysate was ana-
lyzed using the Bradford Assay (Bio-Rad). Then, 60 mlo f
Anti-FLAG M2 Agarose beads (Sigma, Catalog No. A-
2220) solution was added to a centrifuge tube and washed
twice with cold TBS (50 mM Tris–HCl, pH 7.5 and 150 mM
NaCl). The cell lysates were adjusted to 3 mg/ml with
TBS. The suspensions were incubated at 4 C for 3 h with
shaking gently. After incubation, the suspensions were cen-
trifuged at 7000 g at 4 C and washed 4· with cold TBS,
removing all the supernatant after the fourth wash. Then after
adding 30 ml SDS sample loading buffer and boiling for 5 min,
Table 1. APE1-EGFP fusion proteins
EGFP fusion Amino acid sequence of the N-terminus
WT APE1
1MPKRGKKGAV
11AEDGDELRTE
21PEAKKSKTAA
31KKNDKEAAGE
41GPALYEDPP...
ND41 APE1
1MPALYEDPP...
ND20 APE1
1MPEAKKSKTAA
31KKNDKEAAGE
41GPALYEDPP...
APE1 (K6R/K7R)
1MPKRGRRGAV
11AEDGDELRTE
21PEAKKSKTAA
31KKNDKEAAGE
41GPALYEDPP...
APE1 (K6L/K7L)
1MPKRGLLGAV
11AEDGDELRTE
21PEAKKSKTAA
31KKNDKEAAGE
41GPALYEDPP...
APE1 (Lall)
1MPLLGLLGAV
11AEDGDELRTE
21PEAKKSKTAA
31KKNDKEAAGE
41GPALYEDPP...
ND7 APE1
1MGAV
11AEDGDELRTE
21PEAKKSKTAA
31KKNDKEAAGE
41GPALYEDPP...
ND7 APE1(V10A)
1MGAA
11AEDGDELRTE
21PEAKKSKTAA
31KKNDKEAAGE
41GPALYEDPP...
ND7 APE1(E12A/D13A)
1MGAV
11AAAGDELRTE
21PEAKKSKTAA
31KKNDKEAAGE
41GPALYEDPP...
APE1(E12A/D13A)
1MPKRGKKGAV
11AAAGDELRTE
21PEAKKSKTAA
31KKNDKEAAGE
41GPALYEDPP...
N20
1MPKRGKKGAV
11AEDGDELRTE-EGFP
TheN-terminalsequencesoftheAPE1-EGFPfusionproteinsusedinthisstudyareshown.Pointmutationsintroducedinsomeoftheconstructsareindicatedasbold
letters. Note that the first Met, numbered as one in this table, is removed after translation.
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followed by western blotting, using antibodies for APE1 (18),
FLAG (anti-FLAG M2-Peroxidase conjugate, Sigma), Kap a1
(Santa Cruz) and Kap a2 (Santa Cruz).
RESULTS
Nuclear localization of N-terminally truncated APE1
Weﬁrstexaminedthesubcellulardistribution oftheWTAPE1
fused to EGFP in BALB/c 3T3 mouse ﬁbroblasts (Figure 1A).
Based on ﬂuorescence, the EGFP-tagged APE1 was localized
predominantly in the nuclei, consistent with the previous study
(31). The EGFP expression vector pEGFP-N1 was used as a
control. In contrast to APE1-EGFP, the EGFP ﬂuorescence
was found predominantly in the cytoplasm, although a low
level of EGFP was also visible in the nuclei (Figure 1B). The
obvious candidate for the NLS was the N-terminal region. We
thus examined the intracellular distribution of ND41 APE1-
EGFP, in which the N-terminal 41 amino acid residues of
APE1 were deleted (39). (The N-terminal sequences of the
APE1 mutants are listed in Table 1, and the intensities of
EGFP in nuclei versus total intensities were calculated for
the APE1-EGFP constructs in this study, and are shown in
Table 2). This fusion polypeptide was distributed throughout
the cells, with a higher level in the cytoplasm compared to
nuclei (Figure 1C and Table 2). The distribution was similar to
that of EGFP alone, indicating that the deletion resulted in a
substantial reduction in nuclear targeting. To further deﬁne the
sequence responsible for the nuclear targeting, the cells were
transfected with ND20 APE1-EGFP, deleting the N-terminal
20 amino acid residues (Figure 1D and Table 2). The intra-
cellular distribution of ND20 APE1 was similar to that of
ND41 APE1 or EGFP alone. Furthermore, the subcellular
distributions of all the APE1-EGFP fusion proteins in live,
unﬁxed cells were similar to those in the ﬁxed cells (data not
shown).Wethereforeconcluded thatthe NLSislocatedwithin
the ﬁrst 20 amino acid residues, consistent with the prediction
that the ﬁrst seven amino acid residues serve as the NLS (31).
Lack of effect of APE1 acetylation on
nuclear localization
It was recently reported that acetylation of APE1 occurs at
Lys-6 and Lys-7 residues (20). Because these residues are
components of the putative NLS, it appeared possible that
such posttranslational modiﬁcations regulate nuclear translo-
cation of APE1 by eliminating the basicity of these residues.
To test this possibility, Lys-6/Lys-7 was replaced with Arg in
APE1 (K6R/K7R). Arg is slightly larger than Lys, and more
basic, but cannot be acetylated. No signiﬁcant difference in
nuclear localization was observed between the WT APE1 and
the K6R/K7R mutant (Figure 1E and Table 2). We also
examined the K6L/K7L mutant, APE1 (K6L/K7L). The
Leu side chain is hydrophobic, unlike that in Lys, but similar
in size. This mutant also behaved similar to the WT and K6R/
K7R mutant, being localized predominantly in the nucleus
WT APE1
ND20 APE1 ND41 APE1
GFP alone
GFP
TM SI
PI
GFP
TM SI
PI
GFP
TM SI
PI
GFP
TM SI
PI
APE1(K6R/K7R)
GFP
TM SI
PI
APE1(K6L/K7L)
GFP
TM SI
PI
A
C
E F
D
B
Figure 1. (A–D) Intracellular localization of WT and truncated APE1-EGFP
fusion proteins in mouse fibroblasts: (A) WT APE1-EGFP; (B) GFP vector
alone (C) ND41 APE1-EGFP and (D) ND20 APE1-EGFP. (E and F) Effect of
mutation of Lys-6 and Lys-7 on nuclear localization of APE1: (E) APE1(K6R/
K7R)-EGFPor(F)APE1(K6L/K7L)-EGFP.Cellswerefixedwithparaformal-
dehyde and stained with propidium iodide (PI). TM, transmission; SI, super-
imposition of EGFP and PI.
Table 2. Nuclear distribution of various EGFP fusion proteins
EGFP fusion proteins Nuclear fraction
(% of total)
EGFP 12.4 – 3
WT APE1-EGFP 97.2 – 3.6
N20-EGFP 54.9 – 5.2
ND20 APE1-EGFP 40.5 – 3.3
ND41 APE1-EGFP 32.3 – 2.5
APE1(K6R/K7R)-EGFP 85.6 – 6.4
APE1(K6L/K7L)-EGFP 87.2 – 5
APE1(Lall)-EGFP 68.5 – 8.2
ND7 APE1-EGFP 77.2 – 6.6
ND7 APE1(V10A)-EGFP 75.3 – 2.6
ND7 APE1(E12A/D13A)-EGFP 32.8 – 8.1
Full-length APE1(E12A/D13A)-EGFP 74.5 – 2.8
ND7-APE1(E12A/D13A)-EGFP+LMB 92.7 – 2.5
Intensities of whole cells and of nuclei were measured and ratios of nuclear
versus whole cell intensities were calculated from >30 individual cells in each
experiment.
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their acetylation are not required for regulation of the intra-
cellular localization of APE1.
The putative NLS is dispensable for nuclear localization
Because Lys-6/Lys-7, the basic residues in the putative NLS,
were not required for APE1’s nuclear import, we sought to
identify basic residue(s) in the N-terminal region required for
nuclear localization. All basic residues in the putative NLS
(
2PKRGKK
7) were simultaneously mutated to Leu. The mut-
ant, K3L/R4L/K6L/K7L (
2PLLGLL
7), named APE1 (Lall),
was also predominantly localized in the nucleus (Figure 2A
and Table 2). Although a small fraction of APE1 (Lall) was
found to be cytoplasmic (Table 2), it was evident that the
APE1 (Lall), unlike the ND20 and ND41 APE1, retained a
functional NLS. Moreover, the intracellular distribution of
ND7 APE1-EGFP, which lacks the putative NLS segment
(Table 1), was almost identical to that of APE1(Lall)-EGFP
(Figure 2B and Table 2); i.e. the majority of ND7 APE1-EGFP
was translocated to the nucleus. These results indicated that
the NLS is present within the 20 N-terminal amino acid
residues of APE1, but contrary to the earlier prediction, the
putative NLS is dispensable.
We tested whether the N-terminal20 amino acid residues by
themselves could provide the signal for nuclear translocation
of EGFP (Figure 2C). Although the fusion protein, N-terminal
20-EGFP (N20-GFP), was distributed both in the nucleus and
the cytoplasm, the intensity of EGFP ﬂuorescence was dis-
tinctly higher in the nucleus than in the cytosol (Table 2). This
result suggested that the ﬁrst 20 amino acid residues are
enough to translocate APE1 into the nucleus.
Role of E12 and D13 in APE1 nuclear localization
We also examined the subcellular distribution of ND13
APE1 and ND16 APE1 deletion mutants fused to a FLAG
epitope tag at the C-terminus. Unlike the WT APE1-FLAG,
the deletion mutants were primarily present in the cytoplasm
(data not shown). The sequence between residues 8 and 13
(
8GAVAED
13) contains small and nonpolar residues
(
8GAVA
11), followed by two acidic residues (
12ED
13).
V10 was changed to Ala (V10A) in the ND7 APE1
(Table 1) to decrease the hydrophobicity of this region. The
intracellular distribution of ND7 APE1(V10A)-EGFP was
identical to that of ND7 APE1-EGFP (Figure 2D).
Next, both 12E and 13D residues were changed to Ala. The
double mutant ND7 APE1(E12A/D13A) showed signiﬁcant
reduction in nuclear level, resulting in an almost identical
distribution to that of EGFP alone, or the ND20 and
ND41 APE1 mutants (Figure 2E). These results
indicated that E12 and/or D13 play a critical role in nuclear
localization.
Role of the N-terminal residues in nuclear localization
The E12A/D13A double mutations were then introduced
into the full-length APE1-EGFP fusion polypeptide. Unlike
the E12A/D13A in ND7 APE1, this mutant protein was
found predominantly in nuclei (Figure 2F), although careful
examination revealed some inhibition of nuclear localiza-
tion compared to the WT-APE1 (Table 2). These results
suggested that the N-terminal seven amino acid residues
can complement the E12A/D13A mutations in promoting nuc-
lear import.
ND7 APE1 APE1(Lall)
GFP
GFP
TM SI
SI
PI
N20
GFP
TM SI
PI
PI
ND7 APE1(V10A)
GFP
TM SI
PI
ND7 APE1(E12A/D13A)
GFP
TM SI
PI
full APE1(E12A/D13A)
GFP
TM SI
PI
A BC
DEF
Figure 2. EffectofN-terminalmutationinAPE1onthenuclearlocalization:(A)APE1(Lall)-EGFP,(B)ND7APE1-EGFP,(C)N20-EGFP,(D)ND7APE1(V10A)-
EGFP, (E) ND7 APE1(E12A/D13A) and (F) full-length APE1(E12A/D13A). Cells were fixed and stained with PI.
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To deﬁne the mechanism of nuclear import more precisely, we
examined the interactions between APE1 and the nuclear
importins, Kap a1 and a2. FLAG-tagged, full-length APE1
was transiently expressed in HCT116 human colon carcinoma
cells, and was pulled down by anti-FLAG antibody. Using
the corresponding antibodies, both Kap a proteins were detec-
ted in the extract enriched with the FLAG-APE1. In a mock
experiment, where FLAG-immunoprecipitation was carried
out after transfection with a control vector expressing FLAG
peptide alone, neither karyopherin was detected (Figure 3).
To analyze the interaction in vitro, recombinant human Kap
a2 was puriﬁed as previously described (40). The interaction
between APE1 and Kap a2 was then conﬁrmed by far-western
analysis using an anti-Kap a2 antibody (Figure 4A–C); Kap
a2 clearly interacted with the full-length APE1. However, the
truncated APE1 proteins ND20 and ND33 did not show any
afﬁnity for Kap a2 (Figure 4A–C). A similar result was
obtained when the APE1 protein was pulled down with the
His-tagged Kap a2 protein (Figure 4D). Again, interaction
with the ND33 APE1 (N-terminal 33 amino acid deletion)
was not detectable, conﬁrming the importance of the N-
terminal residues. Although we did not analyze the interaction
withKapa1, asimilar mechanismmay mediatethe interaction
between APE1 and Kap a1, because Kap a2 can substitute for
Kap a1 in binding to NLS and in proper nuclear export of a
target protein (40).
Introduction of mitochondrial translocation signal
(MTS) into APE1
Understanding the transport mechanism for APE1 may
enable engineering the APE1 molecule for localization in a
particular organelle. This possibility was tested by replac-
ing the N-terminal 20 amino acid residues of APE1 with the
MTS of the human mitochondria-speciﬁc Mn
2+-superoxide
dismutase (MnSOD) gene (42). The FLAG-tagged MTS-
APE1 was clearly localized in the mitochondria, with
hardly any nuclear ﬂuorescence (Figure 5A). Mitochondrial
localization of the MTS-APE1 was further conﬁrmed by
intensity analysis of Mito-Tracker (mitochondrial) and
FITC (FLAG epitope) markers (Figure 5B). It is thus possible
to control APE1’s subcellular distribution by adding a speciﬁc
localization signal for a subcellular compartment such as the
mitochondria.
Nuclear accumulation of ND7 APE1(D12A/E13A) upon
inhibition of nuclear export
Two processes regulate nuclear/cytoplasmic distribution of
proteins. One is nuclear import through the NLS; alternatively,
a decrease in nuclear export will result in accumulation of
proteins in nuclei (43,44). Since a small fraction of ND7
APE1(E12A/D13A) was still found in nuclei (Table 2), we
asked whether the nuclear distribution of APE1 was affected
by leptomycin B (LMB), a speciﬁc inhibitor of nuclear export
(36,45). As a positive control for LMB, the intracellular dis-
tribution of IkBa-EGFP, the inhibitor of the transcriptional
regulator NF-kB, was monitored (36) (Figure 6A). The IkBa-
EGFP accumulated in the nucleus after a 2 h incubation with
5 nM LMB, as reported previously (Figure 6A) (36). The
distribution of the ND7 APE1(E12A/D13A) mutant, which
showed a marked increase in cytoplasmic distribution under
normal conditions, was examined after LMB treatment. Sur-
prisingly, the majority of ND7 APE1(E12A/D13A) molecules
were found in the nuclei (Figure 6B and Table 2). Because
there was no effect of LMB on the distribution of EGFP alone
(46), this result suggested that APE1 contains an NES.
DISCUSSION
Our ﬁrst objective in this study was to determine the subcel-
lular localization of the WT APE1. Using BALB/C 3T3, our
results were consistent with the earlier report (31), in that
APE1 molecules were exclusively present in the nuclei.
The pattern was not affected whether the cells were live or
ﬁxed, or by the method of ﬁxation or type of reporter peptide
Kapα1 Ab Kapα2 Ab
Kapα1 Kapα2
vector
APE1-FLAG
vector
APE1-FLAG A B
Figure 3. Interaction of APE1 with Kap a1 and a2 analyzed by FLAG-
immunoprecipitation. HCT116 cells were transiently transfected with a vector
control or with a plasmid DNA expressing C-terminally FLAG-tagged APE1.
TheextractswereprocessedwithimmunoprecipitationusingFLAGantibodyto
enrich the APE1-FLAG protein, and were analyzed by western blotting using
Kap a1( A) or Kap a2( B) antibody.
AB
C
1       2      3      4 1      2      3     4      5      6     7
1      2      3     4      5      6     7
APE1 Ab
1       2        3       4
D
Figure 4. Analysis of the interaction between APE1 and Kap a2 proteins: (A)
20 pmol of full-length APE1 (lane 1), ND33 (lane 2), ND20 (lane 3) or BSA
(lane 4) were immobilized onto a nitrocellulose membrane, and probed with
recombinant Kap a2 protein. Interaction was determined using Kap a2
antibody. (B) Far-western with full-length APE1 at 10 pmol (lane 1), 20 pmol
(lane 2) or 40 pmol (lane 3); and ND20 APE1 at 10 pmol (lane 4), 20 pmol
(lane5),40pmol(lane6)orBSA(lane7)probedwithKapa2proteinfollowed
bydetectionofKapa2withitsantibody.(C)Far-westernwithfull-lengthAPE1
at 10 pmol(lane 1), 20 pmol(lane 2) or 40 pmol(lane 3); and ND33 at 10 pmol
(lane 4), 20 pmol (lane 5), 40 pmol(lane 6) or BSA (lane 7) probed in the same
way as in (B). (D) Interaction between APE1 and Kap a2 analyzed by His-tag
pull-down assay. Kap a2 protein (15 mg), N-terminally tagged with histidine
hexamer (His-tag Kap a2), was incubated with no protein (lane 1), 3 mgo fW T
APE1 (lane 2), ND33 APE1 (lane 3) or ND20 APE1 (lane 4) purified through
Ni-NTAresin.Theeluentswereanalyzedwithanti-APE1antibody.Thearrows
indicate the band positions of the full-length APE1 protein.
3308 Nucleic Acids Research, 2005, Vol. 33, No. 10(EGFP or FLAG). This is in contrast to the previous
observations of the endogenous APE1; in human tissues,
APE1 was found in the cytoplasm at a signiﬁcant level
when determined by immunocytochemistry with anti-APE1
antibodies (27–29). The ratio between cytoplasmic and nuc-
lear APE1 might vary based on the tissue type, cell line and
growth conditions (28,29). Importantly, the endogenous APE1
was also found to accumulate in the nuclei after ROS genera-
tion and during the apoptotic process (27,30). Therefore, cells
seem to use the cytoplasm to store extra APE1 that may be
needed in the nuclei under conditions of stress. While it was
not clear why the ectopic APE1 molecules were mostly
localized in the nuclei in the BALB/C cells, this cell line
(with its high transfection efﬁciency compared to that of
HeLa cells; unpublished data) provided a convenient tool
with which to identify APE1’s NLS.
Our results with ND41-, ND20-, ND7- and Lall-APE1
compared to EGFP led us to conclude that residues between
8 and 20 are important for proper nuclear localization. Further
analysis with ND13- and ND16-FLAG APE1 narrowed the
region to the 8th through 13th amino acids.
Small and hydrophobic residues are the main component of
residues 8–13 (
8GAVAED
13), except for the last two acidic
residues. Our data suggest that these acidic residues, Glu-12
and/or Asp-13, are indeed critical for APE1’s nuclear local-
ization. The localization of E12A/D13A on the ND7 back-
ground was essentially identical to that of ND20, and
completelydifferentfromthatofND7,whileaV10Amissense
mutationinND7APE1hadnoeffectonnuclearlocalization.It
is unlikely that the dual missense mutation caused signiﬁcant
conformational change, because the N-terminal 6 kDa is
known to be a distinct, unstructured domain separated from
the 30 kDa domain containing the catalytic domain (38,39,47).
Moreover, the double mutation had only a slight effect on the
subcellular distribution of full-length APE1, supporting the
idea that the mutations did not affect the overall structure
of APE1. We thus propose that APE1 has two separate, inde-
pendent NLS segments. One consists of the N-terminal seven
amino acid residues that form an NLS of the classical pat7
type, and the other is the segment from the 8th to 13th residues
revealed in this study. Our data indicate that either segment,
but not both, can be mutated without signiﬁcantly affecting
A
B
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Figure 5. Localization of APE1 fused to MTS of the MnSOD. (A) Upper panel: a schematic diagram showing replacement of N1–20 amino acid residues of APE1
withMnSODMTSattheN-terminus.TheMTS-APE1isfusedwiththeFLAGpeptideattheC-terminus.Lowerpanel:theBALB/ccellsweretransfectedwithcDNA
encoding the MTS-APE1-FLAG, and then stained with monoclonal anti-FLAG antibody (M2) conjugated to FITC, and then with Mitotracker after fixation.
(B) Intensities scanned along with the lines (1 and 2) denoted in the left panel, using LSMmeta (Carl Zeiss), are shown at the top plots, and correlation between
Mitotracker (red) and FITC (green) are shown in the bottom plots. Arbitrary units are shown in both types of plots.
Nucleic Acids Research, 2005, Vol. 33, No. 10 3309efﬁcient nuclear localization. The peptide comprising residues
8–13 contains two acidic residues, and lacks the signature of a
classical NLS. Interestingly, NLS without the classical con-
sensus sequences are already known. For example, the NLS
of the c-Myc protein contains essential acidic amino acid
residues (48).
Nuclear importins play a central role in importing target
proteins into nuclei. Particularly, Kap a1 and a2 can interact
with the target proteins by binding to their classical NLS (34).
Our observation that APE1 interacts with Kap a1 and a2 sug-
ests that APE1’s nuclear transport is mediated by these
importin proteins. The interaction was observed both between
the recombinant proteins (by far-western and His-tag pull-
down assays) and with cell-free extracts (FLAG-tagged
APE1-immuno pull-down assay). Although our study did
not dissect the two NLS segments for Kap a speciﬁcity, it
is likely that APE1’s classical NLS (
2PKRAKK
7) is respons-
ible for the interaction, because Kap a proteins are known to
interact with classical NLS (34). It may be interesting to
examine how APE1’s distribution is affected by the level of
cytosolic/nuclear Kap a2, of which nuclear import/export is
also regulated by a cellular physiological status (49).
The lack of cytoplasmic distribution of transiently transfec-
ted APE1 made it difﬁcult to systematically test the possibility
of the presence of a nuclear export signal in APE1. We noticed
that a small fraction of ND7 APE1(E12A/D13A) was still
localized in the nuclei. The intrinsic properties of EGFP, a
small fraction ofwhich tends to bepresent innuclei(Figure 1B
and Table 2), may account for this result. Alternatively, it is
possible that APE1 has tendency to localize in nuclei even
without the N-terminal NLS. However, considering some
prokaryotic and bacteriophage proteins are known to enter
nuclei of mammalian cells (50,51), it is not clear whether
the small tendency of nuclear localization of APE1 lacking
the NLS has a physiological role. In any case, the ND7
APE1(E12A/D13A) was used to test whether APE1 responds
to LMB, a general nuclear export inhibitor (52). To our know-
ledge, the present study is the ﬁrst to show nuclear accumu-
lation of APE1 upon LMB treatment. A nearly identical
response was observed with IkBa (36), so a similar mechan-
ism may mediate nuclear export of APE1 by the nuclear export
protein CRM1 (52).
A CRM1-dependent NES is typically a 10–20 amino acid
long sequence containing a few Leu residues (52). Since
APE1’s N-terminal 6 kDa region is not conserved with the
E.coli exonuclease III, an APE1 ortholog, it is often speculated
that this region may be linked to mammalian-speciﬁc func-
tions such as nuclear import/export. However, of 37 Leu
residues in APE1, there are only two (L17 and L44) in the
N-terminal 6 kDa peptide. Therefore, it is unlikely that the
NES is in the N-terminal 6 kDa region. Examining the 3D
structures (39) revealed that
281RLDYFLLSHS LLPALCD-
SKI
300 near the C-terminus contains 6 Leu residues, of which
L291, L292 and L295 are exposed on the surface of the APE1
molecule. These Leu residues are localized in a very short
a-helix between two b-sheet structures. Other Leu-rich
regions can be also found on the surface:
101ENKLPAEL-
QELPGLSHQYWS
120,
131VGLLSRQCPL
140,
191AFRK-
FLKGLA
200,
241GELLQAVPLA
250 and
311PITLYLAL
318.
In the future, it should be possible to identify the NES by
examining Leu mutants in the ND7 APE1(E12A/D13A). Ana-
lyzing the interaction of APE1 with CRM1 and identifying
APE1’s domain for the interaction would also help further
elucidate the nuclear export mechanism of APE1.
Although APE1 has been known to be present in the cyto-
plasm (27), it is not clear why in some cells APE1 is localized
in both the nuclei and cytoplasm, whereas transiently
expressed APE1 can be detected mostly in the nuclei of
BALB/c 3T3 and HeLa cells. The present study indicates
that the distribution of APE1 in the nucleus and cytosol is
in a dynamic equilibrium. In HeLa cells, APE1 is translocated
into nuclei after the cells are exposed to ROS including H2O2
(27). It is possible that decreased nuclear export is responsible
for the nuclear accumulation of APE1. Whether APE1 accu-
mulation in nuclei after ROS generation is due to CRM1
inhibition clearly needs further study. Examining the activity
of the importin and exportin proteins speciﬁc to APE1 in each
cell type should reveal the complex mechanism used to regu-
late the subcellular distribution of APE1, an essential multi-
functional protein.
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